Eli Lilly outlays $3.35bn for secretive drug discovery pact with China’s InnoCare
Eli Lilly has partnered with China-based InnoCare Pharma in a five-drug strong research and license pact. As per the deal,…
News
Australia starts investigation into OpenAI Medicare breach
Enveda nabs $311m to progress nature-derived drug pipeline
Genialis and Inventia to enhance pancreatic cancer treatment testing
Basecamp Research secures $140m for AI-driven therapies
European big pharma unites amid ‘ringing alarm bells’ of continent’s dominance
BoomRay and Novartis sign $900m deal for radioligand therapy
Boehringer and Envisagenics to develop precision cancer therapies in $1bn deal
